A SINGLE-ARM OPEN-LABEL INTERNATIONAL MULTI-CENTER STUDY OF THE EFFICACY AND SAFETY OF SUNITINIB MALATE (SU011248, SUTENT (REGISTERED)) IN PATIENTS WITH PROGRESSIVE ADVANCED METASTATIC WELL-DIFFERENTIATED UNRESECTABLE PANCREATIC NEUROENDOCRINE TUMORS
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008888/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to confirm the safety and efficacy of sunitinib in subjects with
unresectable pancreatic neuroendocrine tumors.
提供机构：
Vivli
创建时间：
2023-04-12
